Rimonabant - CISMeF

Preferred Label : Rimonabant;

MeSH definition : A pyrazole and piperidine derivative that acts as a selective cannabinoid type-1 receptor (CB1 RECEPTOR) antagonist. It inhibits the proliferation and maturation of ADIPOCYTES, improves lipid and glucose metabolism, and regulates food intake and energy balance. It is used in the management of OBESITY.;

MeSH hyponym : SR 141716; N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride; SR-141716A; SR141716A;

MeSH CAS label : 1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-;

MeSH Related Number : 158681-13-1 (Rimonabant); HL0V2LQZ09;

UNII : RML78EN3XE;

Details

Origin ID

D000077285;

UMLS CUI

C1142933;

ATC code(s)
- antiobesity preparations, excl. diet products [ATC Code]
- antiobesity preparations, excl. diet products [ATC Code]
- rimonabant [ATC Code]
ATC code(s)
- rimonabant [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Rimonabant [NCIt concept]
- Rimonabant [ICD-11 Extension code]
- Rimonabant (substance) [SNOMED CT concept]
- rimonabant [Substance BNPC]
Pharmacological action(s)
- anti-obesity agents [MeSH Descriptor]
- cannabinoid receptor antagonists [MeSH Descriptor]
- hormones [MeSH Descriptor]
- neurotransmitter agents [MeSH Descriptor]
Record concept(s)
- Rimonabant Hydrochloride [MeSH concept]
- SR 141716A [MeSH concept]
- SR141716 [MeSH concept]
- Zimulti [MeSH concept]
- acomplia [MeSH concept]
- rimonabant [MeSH concept]
See also inter- (CISMeF)
- Product containing rimonabant (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing rimonabant (medicinal product) [SNOMED CT concept]
- Rimonabant [NCIt concept]
- Rimonabant (substance) [SNOMED CT concept]
- rimonabant [ATC Code]
Validated automatic mappings to BTNT
- rimonabant [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients